Phase III Approval UpdatesAugust 16, 2021 0Clinical Trials Regulatory roundup: Sanofi/Regeneron, J&J and Eyenovia boost approval chances with Phase III updates
Servier, Pfizer and Debiopharm gather gainsAugust 13, 2021 0Clinical Trials Regulatory roundup: Servier, Pfizer and Debiopharm gather gains with oncology trial updates; Karyopharm poses a loss
The 5 Pillars Of Clinical Trial Material ManagementJuly 16, 2020 0Clinical Trials Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed vel dolor aliquet, sollicitudin elit eget, egestas arcu. Cras a tristique tellus, nec congue leo.